Fate Therapeutics, Inc.FATENASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank21
3Y CAGR-39.4%
5Y CAGR-52.4%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-39.4%/yr
vs -29.6%/yr prior
5Y CAGR
-52.4%/yr
Recent acceleration
Acceleration
-9.8pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $3.06M | - |
| 2024 | $0.00 | -100.0% |
| 2023 | $157.19M | +1042.5% |
| 2022 | $13.76M | +135.2% |
| 2021 | $5.85M | -95.3% |
| 2020 | $125.62M | - |
| 2019 | $0.00 | -100.0% |
| 2018 | $56.02M | +63.1% |
| 2017 | $34.36M | +29.9% |
| 2016 | $26.45M | - |